Shockwave therapy for Peyronie's disease: what the evidence actually shows

What did @medsurgery418 actually say?

The creator claims that low-intensity shockwave therapy (Li-ESWT) breaks down scar tissue in Peyronie's disease, reduces pain, and improves curvature and function through a series of non-invasive sessions. They describe it as "a safe, modern option" and recommend seeing a urologist early because "the sooner treatment starts, the better your chance is of recovery." That last point about early intervention is the most clinically defensible thing in the video.

The framing is broadly accurate but skips over some significant limitations that any honest urologist would want patients to know before booking sessions. The video also incorrectly categorizes this under TRT content, which has nothing to do with Peyronie's treatment. That's a metadata problem, not a clinical one, but worth noting.

Does the science back this up?

Partially. The evidence for Li-ESWT in Peyronie's disease is real but decidedly mixed, and the creator's optimistic framing glosses over that reality.

A 2016 randomized controlled trial by Palmieri et al. published in the Journal of Sexual Medicine found improvements in pain and erectile function scores with Li-ESWT, but no statistically significant reduction in penile curvature compared to sham treatment. That's a big caveat that never makes it into TikTok videos. A 2021 systematic review by Sokolakis and Hatzichristodoulou in Translational Andrology and Urology concluded that current evidence does not support Li-ESWT as a standalone treatment for correcting curvature, though it may help with pain and erectile function as an adjunct therapy. The American Urological Association's 2022 guidelines on Peyronie's disease do not list shockwave therapy as a first-line recommendation for curvature correction specifically because the RCT data is weak on that endpoint.

So: pain relief and functional improvement, plausible. "Break down the scar tissue" and straighten the penis, not well-supported by the best available evidence.

What did they get wrong (or right)?

Let's be specific. The creator gets credit for telling viewers to see a urologist and for flagging early intervention as important. That aligns with what the AUA actually recommends, since the acute inflammatory phase of Peyronie's disease is the window where conservative treatments have the best shot.

What they got wrong, or at least oversold, is the mechanism and the outcomes. Describing shockwave as something that will "break down the scar tissue" implies a structural correction that the RCT data simply does not consistently support. The Palmieri 2016 trial is the most cited randomized evidence, and it showed no significant change in curvature. The phrase "many men experience a noticeable improvement in shape" is doing a lot of work without citing any numbers.

• Pain reduction: reasonably supported
• Erectile function improvement: some support, likely via improved penile blood flow
• Curvature correction: not well-supported as a standalone mechanism
• "Break down scar tissue": mechanistically plausible but clinically unproven at the tissue level in humans

The video also doesn't mention that collagenase clostridium histolyticum (Xiaflex) is the only FDA-approved injectable treatment for Peyronie's, and surgical plication or grafting remains the gold standard for significant curvature. Patients deserve that context.

What should you actually know?

Peyronie's disease affects an estimated 0.5% to 13% of men depending on the population studied, according to Stuntz et al. 2016 in PLOS ONE, so the "too many people suffer in silence" framing is fair. It is underdiagnosed and under-discussed.

But if you're a man watching this video and thinking shockwave therapy is going to straighten a significant curvature, you may be disappointed. The current evidence supports it most strongly as an adjunct for pain management and possibly erectile function, not as a curvature-correcting treatment. If your curvature is greater than 30 degrees or is affecting sexual function significantly, the conversation with your urologist should include Xiaflex injections or surgical options, not just shockwave.

The recommendation to see a urologist early is genuinely good advice. The acute phase of Peyronie's disease, typically the first 12 to 18 months when the plaque is still forming, is when oral antioxidants like pentoxifylline and intralesional injections have the most potential impact. Waiting it out is not a neutral choice.

One more thing: this video is categorized under TRT content on this platform. Shockwave therapy for Peyronie's disease has no meaningful connection to testosterone replacement therapy. Don't conflate the two.